← Evidence map

ArticleJournal of the American College of Cardiology2022

Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19.

Arnoldo Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34991793